European regulators plan more rigorous rules for accelerated approval in cancer.
Cancer Policy Board urges distinct care for cancer survivors.
MSKCC oncologist settles insider trading case with SEC.
Richard Pestell, of Georgetown University, to direct Kimmel Cancer Center at Thomas Jefferson University.
NCI funds biorepository for prostate cancer SPOREs.
Three researchers share Paul Marks Prize.
ASCO, NCCS form cancer quality alliance.
Bill Clinton, NBCC establish fund to honor former President’s late mother.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
